![Advanced Methods for Dose and Regimen Finding During Drug Development: Summary of the EMA/EFPIA Workshop on Dose Finding (London 4–5 December 2014) - Musuamba - 2017 - CPT: Pharmacometrics & Systems Pharmacology - Wiley Online Library Advanced Methods for Dose and Regimen Finding During Drug Development: Summary of the EMA/EFPIA Workshop on Dose Finding (London 4–5 December 2014) - Musuamba - 2017 - CPT: Pharmacometrics & Systems Pharmacology - Wiley Online Library](https://ascpt.onlinelibrary.wiley.com/cms/asset/a238bd50-fef2-4b65-a5c6-f72db5d122a1/psp412196-fig-0001-m.jpg)
Advanced Methods for Dose and Regimen Finding During Drug Development: Summary of the EMA/EFPIA Workshop on Dose Finding (London 4–5 December 2014) - Musuamba - 2017 - CPT: Pharmacometrics & Systems Pharmacology - Wiley Online Library
![Dose-ranging study performed in Gucy2f -/-mice to determine optimal... | Download Scientific Diagram Dose-ranging study performed in Gucy2f -/-mice to determine optimal... | Download Scientific Diagram](https://www.researchgate.net/publication/371231698/figure/fig1/AS:11431281170632069@1687839976955/Dose-ranging-study-performed-in-Gucy2f--mice-to-determine-optimal-dose-of-editing.png)
Dose-ranging study performed in Gucy2f -/-mice to determine optimal... | Download Scientific Diagram
![Multidimensional Phase I Dose Ranging Trials for Stroke Recovery Interventions: Key Challenges and How to Address Them - Emily J. Dalton, Leonid Churilov, Natasha A. Lannin, Dale Corbett, Bruce C. V. Campbell, Multidimensional Phase I Dose Ranging Trials for Stroke Recovery Interventions: Key Challenges and How to Address Them - Emily J. Dalton, Leonid Churilov, Natasha A. Lannin, Dale Corbett, Bruce C. V. Campbell,](https://journals.sagepub.com/cms/10.1177/15459683211019362/asset/images/large/10.1177_15459683211019362-fig4.jpeg)
Multidimensional Phase I Dose Ranging Trials for Stroke Recovery Interventions: Key Challenges and How to Address Them - Emily J. Dalton, Leonid Churilov, Natasha A. Lannin, Dale Corbett, Bruce C. V. Campbell,
![Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study - The Lancet Neurology Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study - The Lancet Neurology](https://www.thelancet.com/cms/attachment/097d689b-94cc-46cd-8a41-68b6055e1777/gr1.gif)
Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study - The Lancet Neurology
![First dose-ranging study demonstrating the dose-response relationship... | Download Scientific Diagram First dose-ranging study demonstrating the dose-response relationship... | Download Scientific Diagram](https://www.researchgate.net/publication/12150318/figure/fig2/AS:601670681636875@1520460877449/First-dose-ranging-study-demonstrating-the-dose-response-relationship-between-the-dose-of.png)
First dose-ranging study demonstrating the dose-response relationship... | Download Scientific Diagram
![How to design a dose-finding study using the continual reassessment method | BMC Medical Research Methodology | Full Text How to design a dose-finding study using the continual reassessment method | BMC Medical Research Methodology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12874-018-0638-z/MediaObjects/12874_2018_638_Fig7_HTML.png)
How to design a dose-finding study using the continual reassessment method | BMC Medical Research Methodology | Full Text
![Efficient dose-finding for drug combination studies involving a shift in study populations - ScienceDirect Efficient dose-finding for drug combination studies involving a shift in study populations - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S245186542030003X-gr1.jpg)
Efficient dose-finding for drug combination studies involving a shift in study populations - ScienceDirect
![Figure 2, [Design of Dose Range-finding and Prenatal Developmental Toxicity Studies in Rats]. - NTP Developmental and Reproductive Toxicity Technical Report on the Prenatal Development Studies of Vinpocetine (CASRN 42971-09-5) in Sprague Figure 2, [Design of Dose Range-finding and Prenatal Developmental Toxicity Studies in Rats]. - NTP Developmental and Reproductive Toxicity Technical Report on the Prenatal Development Studies of Vinpocetine (CASRN 42971-09-5) in Sprague](https://www.ncbi.nlm.nih.gov/books/NBK559690/bin/DART_03-Image002.jpg)
Figure 2, [Design of Dose Range-finding and Prenatal Developmental Toxicity Studies in Rats]. - NTP Developmental and Reproductive Toxicity Technical Report on the Prenatal Development Studies of Vinpocetine (CASRN 42971-09-5) in Sprague
![Dose Finding in the Clinical Development of 60 US Food and Drug Administration–Approved Drugs Compared With Learning vs. Confirming Recommendations - Lyauk - 2019 - Clinical and Translational Science - Wiley Online Library Dose Finding in the Clinical Development of 60 US Food and Drug Administration–Approved Drugs Compared With Learning vs. Confirming Recommendations - Lyauk - 2019 - Clinical and Translational Science - Wiley Online Library](https://ascpt.onlinelibrary.wiley.com/cms/asset/c7a9edc7-742d-402f-9582-01c70cf86768/cts12641-fig-0001-m.jpg)
Dose Finding in the Clinical Development of 60 US Food and Drug Administration–Approved Drugs Compared With Learning vs. Confirming Recommendations - Lyauk - 2019 - Clinical and Translational Science - Wiley Online Library
![How to design a dose-finding study using the continual reassessment method | BMC Medical Research Methodology | Full Text How to design a dose-finding study using the continual reassessment method | BMC Medical Research Methodology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12874-018-0638-z/MediaObjects/12874_2018_638_Fig5_HTML.png)